This clinical trial studies the effect of a quality of life intervention on decision-making in patients with early-stage lung cancer who are undergoing standard of care surgery or stereotactic body radiation therapy (SBRT). Providing quality of life outcome data to patients deciding between surgery and SBRT may help decrease decision regret and increase patient satisfaction with their care.
Age >= 18 years
Radiographic stage I-II non-small cell lung cancer (NSCLC)
Of note, separate tumor nodule(s) in an ipsilateral lobe different from that of the primary is considered T4 disease. However, these are treated as separate stage I or II lesions and will be eligible for this study.
Eligible for both surgery and SBRT
Radiographic stage III-IV NSCLC except as noted above
Eligible for either only surgery or SBRT, but not both
Eligible for palliative-intent treatments or supportive care only.
Pregnant female participants.
Roswell Park Cancer Institute
Lead sponsor
National Comprehensive Cancer Network
Collaborator